Avience Biomedicals (NSE:AVIENCE) OCF Margin %: 0.00% (As of Jan. 2026)


NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
5 GF Score
Price ₹414.95
View Full Analysis

What is Avience Biomedicals OCF Margin %?

Avience Biomedicals NSE:AVIENCE 5 OCF Margin % is 0.00% as of Jan. 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100. Among 815 Medical Devices & Instruments companies, Avience Biomedicals ranks better than 53.87% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Avience Biomedicals's Cash Flow from Operations for the three months ended in Jan. 2026 was ₹0.0 Mil. Avience Biomedicals's Revenue for the three months ended in Jan. 2026 was ₹0.0 Mil. Therefore, Avience Biomedicals's OCF Margin % for the quarter that ended in Jan. 2026 was 0.00%.

As of today, Avience Biomedicals's current OCF Yield % is 0.00%.

The historical rank and industry rank for Avience Biomedicals's OCF Margin % or its related term are showing as below:

NSE:AVIENCE' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: 7.97

NSE:AVIENCE's OCF Margin % is ranked better than
53.87% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 5.82 vs NSE:AVIENCE: 7.97

Avience Biomedicals OCF Margin % Related Terms

Avience Biomedicals OCF Margin % Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals OCF Margin % Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
OCF Margin %
14.53 4.11 7.97

Avience Biomedicals Quarterly Data
Mar23 Mar24 Mar25 Jan26
OCF Margin % 0.00 0.00 0.00 0.00

NSE:AVIENCE vs ABT, SYK, MDT: OCF Margin % Comparison

For the Medical Devices subindustry, Avience Biomedicals's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avience Biomedicals OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Avience Biomedicals's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Avience Biomedicals's OCF Margin % falls into.


NSE:AVIENCE
5GF Score
Avience Biomedicals Ltd NSE:AVIENCE
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Avience Biomedicals's OCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=36.063/452.36
=7.97 %

Avience Biomedicals's OCF Margin for the quarter that ended in Jan. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jan. 2026 )/Revenue (Q: Jan. 2026 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Avience Biomedicals (NSE:AVIENCE) has a OCF Margin % of 0.00% as of Jan. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Avience Biomedicals and its competitors. According to the industry distribution chart, Avience Biomedicals ranks #376 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 46.1%.
Is Avience Biomedicals' OCF Margin % too high?
Avience Biomedicals' current OCF Margin % is 0.00%. Based on the distribution chart, Avience Biomedicals ranks #376 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Avience Biomedicals ranks #376 out of 815 companies for OCF Margin %. This puts Avience Biomedicals in the upper half of its industry. The industry median OCF Margin % is 5.82. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.82, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Avience Biomedicals and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avience Biomedicals's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current OCF Margin % is 0.00% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score

Get the complete analysis for NSE:AVIENCE

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.95
Price